Cargando…
A 19-year-old patient with atypical chronic myeloid leukemia
Autores principales: | Ernst, Philipp, Engmann, Björn, Frietsch, Jochen J., Schnetzke, Ulf, Scholl, Sebastian, Theis, Bernhard, Kreipe, Hans H., Ernst, Thomas, Glaser, Anita, Haferlach, Torsten, Koch, Thilo, Hochhaus, Andreas, Hilgendorf, Inken |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196939/ https://www.ncbi.nlm.nih.gov/pubmed/32193626 http://dx.doi.org/10.1007/s00277-020-03992-w |
Ejemplares similares
-
Impact of induction chemotherapy with intermediate-dosed cytarabine and subsequent allogeneic stem cell transplantation on the outcome of high-risk acute myeloid leukemia
por: Fleischmann, Maximilian, et al.
Publicado: (2021) -
Outcome of patients with relapsed or refractory acute myeloid leukemia treated with Mito-FLAG salvage chemotherapy
por: Mühleck, Regina, et al.
Publicado: (2021) -
In Vivo Emergence of UL56 C325Y Cytomegalovirus Resistance to Letermovir in a Patient with Acute Myeloid Leukemia after Hematopoietic Cell Transplantation
por: Frietsch, Jochen J, et al.
Publicado: (2019) -
Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia
por: Fleischmann, Maximilian, et al.
Publicado: (2022) -
Treosulfan plus fludarabine versus TEAM as conditioning treatment before autologous stem cell transplantation for B-cell Non-Hodgkin lymphoma
por: Frietsch, Jochen J., et al.
Publicado: (2022)